Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors

Cancer Gene Therapy

Volumn 5, Issue 6, 1998, Pages 350-356

  Di Nicola, Massimo ^a,c   Siena, Salvatore ^a   Bregni, Marco ^a   Longoni, Paolo ^a   Magni, Michele ^a   Milanesi, Marco ^a   Matteucci, Paola ^a   Mortarini, Roberta ^a   Anichini, Andrea ^a   Parmiani, Giorgio ^a   Drexler, Ingo ^b   Erfle, Volker ^b   Sutter, Gerd ^b   Gianni, A Massimo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Forschungszentrum F Umwelt G   (Germany)

^c Istituto Tumori   (Italy)

Author keywords

Adenovirus; CD34+ cells; Dendritic cells; Modified vaccinia Ankara

Indexed keywords

CD34 ANTIGEN;

ADENOVIRUS; ANTIGEN PRESENTING CELL; ARTICLE; COMPARATIVE STUDY; DENDRITIC CELL; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; PHYSIOLOGY; STEM CELL; TIME; VACCINIA VIRUS;

ADENOVIRIDAE; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD34; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; STEM CELLS; TIME FACTORS; TRANSDUCTION, GENETIC; VACCINIA VIRUS;

EID: 0032197463     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12:337-365.
2. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, Coulie P, Boon T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med. 1993;178:489-495.
3. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL, Jr. Identification of a peptide recognized by five melanomaspecific human cytotoxic T cell lines. Science. 1994;264: 716-719.
4. Pardoll DM. Tumor antigens: a new look for the 1990s. Nature. 1994;369:357.
5. Mayordomo JL, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Milif CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat Med. 1995;1:1297-1302.
6. Marchand M, Weynants P, Rankin E, et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer. 1995;63:883-885.
7. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Englemann EG, Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med. 1996;2:52-58.
8. Lanzavecchia A. Identifying strategies for immune intervention. Science. 1993;260:937-944.
9. Steiman RM. Dendritic cells and immune-based therapies. Exp Hematol. 1996;24:859-862.
10. Grabbe S, Beissert S, Schwarz T, Granstein RD. Dendritic cells as initiators of immune responses: a possible strategy for tumor immunotherapy? Immunol Today. 1997;16:117-121.
11. + blood progenitors for anticancer therapy. Exp Hematol. 1995;23:1463-1471.
12. 27-35-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Res. 1997;57: 5534-5541.
13. Alijagic S, Moller P, Artuc M, Jurgovsky K, Czarnetzi BM, Schadendorf D. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol. 1995;25:3100-3107.
14. Aicher A, Westermann J, Cayeux S, Willimsky G, Daemen K, Blankenstein T, Uckert W, Dorken B, Pezzuto AS. Successful retroviral-mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen-presenting cells. Exp Hematol. 1997;215:39-44.
15. Visseren MJ, van Elsas A, van der Voort EIH, Ressing ME, Kast WM, Schrier PI, Melief CJM. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J Immunol. 1995;154: 3991-3998.
16. Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM, Lau R, Dubinett S, Glaspy J, McBride WH, Economou JS. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 1997;4:17-25.
17. Sutter G, Moss B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc Natl Acad Sci USA. 1992;89:10847-10851.
18. Neering SJ, Hardy SF, Minamoto D, Spratt SK, Jordan CT. Transduction of human hematopoietic cells with recombinant adenovirus vectors. Blood. 1996;88:1147-1155.
19. Gianni AM, Siena S, Bregni M, Di Nicola M, Orefice S, Salvadori B, Luini A, Greco M, Zucali R, Rilke F, Zambetti M, Valagusa P, Bonadonna G. Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-years results. J Clin Oncol. 1997;15:2312-2321.
20. Ravagnani F, Siena S, Bregni M, Sciorelli G, Gianni AM, Pellegris G. Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer. 1990;26:562-564.
21. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood. 1991;77:400-409.
22. + blood cells. Br J Haematol. 1996;94:716-721.
23. 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
24. Wan Y, Bramson J, Carter R, Graham F, and Gauldie J. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum Gene Ther. 1997;8:1355-1363.
25. +-mobilized blood progenitor cells. Gene Ther. 1998; In press.
26. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-α. J Exp Med. 1994;179:1109-1118.
27. + T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus. J Immunol. 1996;157:4079-4086.